Cargando…

Increased risk of second malignancies after in situ breast carcinoma in a population-based registry

Among 1276 primary breast carcinoma in situ (BCIS) patients diagnosed in 1972–2002 in the Southern Netherlands, 11% developed a second cancer. Breast carcinoma in situ patients exhibited a two-fold increased risk of second cancer (standardised incidence ratios (SIR): 2.1, 95% confidence interval (CI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soerjomataram, I, Louwman, W J, van der Sangen, M J C, Roumen, R M H, Coebergh, J W W
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2006
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360642/ https://www.ncbi.nlm.nih.gov/pubmed/16804522 http://dx.doi.org/10.1038/sj.bjc.6603231

Ejemplares similares

Scrotal cancer: incidence, survival and second primary tumours in the Netherlands since 1989
por: Verhoeven, R H A, et al.
Publicado: (2010)

Increased risks of third primary cancers of non-breast origin among women with bilateral breast cancer
por: Kwast, A B G, et al.
Publicado: (2012)

On the avoidability of breast cancer in industrialized societies: older mean age at first birth as an indicator of excess breast cancer risk
por: Soerjomataram, Isabelle, et al.
Publicado: (2007)

Impact of a programme of mass mammography screening for breast cancer on socio-economic variation in survival: a population-based study
por: Louwman, W. J., et al.
Publicado: (2007)

Rising incidence of breast cancer among female cancer survivors: implications for surveillance
por: Soerjomataram, I, et al.
Publicado: (2009)

Trends in breast biopsies for abnormalities detected at screening mammography: a population-based study in the Netherlands
por: van Breest Smallenburg, V, et al.
Publicado: (2013)

A 50% higher prevalence of life-shortening chronic conditions among cancer patients with low socioeconomic status
por: Louwman, W J, et al.
Publicado: (2010)

The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands
por: Schaapveld, Michael, et al.
Publicado: (2007)

Patterns of treatment and outcome of ductal carcinoma in situ in the Netherlands
por: Luiten, Jacky D., et al.
Publicado: (2021)

An overview of prognostic factors for long-term survivors of breast cancer
por: Soerjomataram, Isabelle, et al.
Publicado: (2007)

Limited impact of COVID‐19‐related diagnostic delay on cutaneous melanoma and squamous cell carcinoma tumour characteristics: a nationwide pathology registry analysis
por: Sangers, Tobias E., et al.
Publicado: (2022)

Small but significant socioeconomic inequalities in axillary staging and treatment of breast cancer in the Netherlands
por: Aarts, M J, et al.
Publicado: (2012)

Comorbidity has negligible impact on treatment and complications but influences survival in breast cancer patients
por: Houterman, S, et al.
Publicado: (2004)

Second primary malignancies in patients with male breast cancer
por: Hemminki, K, et al.
Publicado: (2005)

Second solid cancers after radiotherapy for breast cancer in SEER cancer registries
por: Berrington de Gonzalez, A, et al.
Publicado: (2010)

Excess mortality from breast cancer 20 years after diagnosis when life expectancy is normal
por: Louwman, W J, et al.
Publicado: (2001)

Family history of breast cancer and young age at diagnosis of breast cancer increase risk of second primary malignancies in women: a population-based cohort study
por: Prochazka, M, et al.
Publicado: (2006)

Risk of subsequent invasive breast carcinoma after in situ breast carcinoma in a population covered by national mammographic screening
por: Rawal, R, et al.
Publicado: (2005)

Pathologic response of ductal carcinoma in situ to neoadjuvant systemic treatment in HER2-positive breast cancer
por: Groen, Emma J., et al.
Publicado: (2021)

Trends in the incidence of adenocarcinoma of the oesophagus and cardia in the Netherlands 1989–2003
por: van Blankenstein, M, et al.
Publicado: (2007)

Ductal carcinoma in situ of the breast, a population-based study of epidemiology and pathology
por: Kricker, A, et al.
Publicado: (2004)

Family history of cancer as a risk factor for second malignancies after Hodgkin's lymphoma
por: Andersson, A, et al.
Publicado: (2008)

Significant inter- and intra-laboratory variation in grading of ductal carcinoma in situ of the breast: a nationwide study of 4901 patients in the Netherlands
por: van Dooijeweert, Carmen, et al.
Publicado: (2018)

Reproductive risk factors and oestrogen/progesterone receptor-negative breast cancer in the Breast Cancer Family Registry
por: Work, M E, et al.
Publicado: (2014)

Extent of ductal carcinoma in situ according to breast cancer subtypes: a population-based cohort study
por: Doebar, Shusma C., et al.
Publicado: (2016)

Reliability of preoperative breast biopsies showing ductal carcinoma in situ and implications for non-operative treatment: a cohort study
por: Mannu, Gurdeep S., et al.
Publicado: (2019)

The association between antihypertensive drugs and glioma
por: Houben, M P W A, et al.
Publicado: (2006)

Prognostic value of morphology and hormone receptor status in breast cancer – a population-based study
por: Allemani, C, et al.
Publicado: (2004)

Second breast cancers in a Tuscan case series: characteristics, prognosis, and predictors of survival
por: Ciatto, S, et al.
Publicado: (2008)

Ductal carcinoma in situ of the male breast: clinical radiological features and management in a cancer referral center
por: Nicosia, Luca, et al.
Publicado: (2022)

Factors associated with late risks of breast cancer-specific mortality in the SEER registry
por: Leone, José P., et al.
Publicado: (2021)

Long-term population-based risks of second malignant neoplasms after childhood cancer in Britain
por: Jenkinson, H C, et al.
Publicado: (2004)

Outcomes for the first four lines of therapy in patients with HER2-positive advanced breast cancer: results from the SONABRE registry
por: Ibragimova, Khava I. E., et al.
Publicado: (2023)

Molecular markers of risk of subsequent invasive breast cancer in women with ductal carcinoma in situ: protocol for a population-based cohort study
por: Rohan, Thomas E, et al.
Publicado: (2021)

Survival before and after the introduction of pertuzumab and T-DM1 in HER2-positive advanced breast cancer, a study of the SONABRE Registry
por: Ibragimova, Khava I. E., et al.
Publicado: (2021)

Familial invasive and in situ squamous cell carcinoma of the skin
por: Hemminki, K, et al.
Publicado: (2003)

Risk and prognostic significance of metachronous contralateral testicular germ cell tumours
por: Schaapveld, M, et al.
Publicado: (2012)

Cohort profile: a nationwide cohort of Finnish military recruits born in 1958 to study the impact of lifestyle factors in early adulthood on disease outcomes
por: Sormunen, Jorma, et al.
Publicado: (2017)

Previously diagnosed multiple primary malignancies in patients with breast carcinoma in Western Sweden between 2007 and 2018
por: Nyqvist, Jenny, et al.
Publicado: (2020)

Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women
por: Elshof, Lotte E., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_600f1arrdrub203qkigi58qv9l